美国甲状腺毒症住院患者中甲状腺危象的十年趋势
基于美国全国住院患者样本数据库,回顾性分析2004至2013年成人甲状腺毒症住院资料,共121,384例出院记录,其中16.2%诊断为甲状腺危象;危象患者院内死亡率与住院时间显著高于无危象者,住院费用逐年上升。
要点
- 每6例甲状腺毒症住院出院中约1例诊断为甲状腺危象。
- 甲状腺危象院内死亡率显著高于无危象甲状腺毒症。
- 十年间甲状腺危象发病率与死亡率无实质变化,住院费用显著上升。
核心结论
- 甲状腺危象约占甲状腺毒症住院出院的六分之一,与无危象者相比死亡率高约12倍。
- 过去十年甲状腺危象的发病率与死亡率未发生实质性变化,但住院费用显著增加。
研究设计与样本
- 回顾性纵向分析,使用美国全国住院患者样本数据库(美国最大的公共住院数据库,代表所有非联邦医院)。
- 纳入2004至2013年年龄≥18岁、主要诊断为甲状腺毒症伴或不伴甲状腺危象的成人。
- 共分析121,384例甲状腺毒症出院记录,平均年龄48.7±0.11岁,51.9%为白人,77.3%为女性。
主要发现
- 19,723例(16.2%)诊断为甲状腺危象。
- 甲状腺危象发病率范围为每年0.57–0.76例/10万美国人口,以及每年4.8–5.6例/10万住院患者。
- 甲状腺危象院内死亡率为1.2–3.6%,无危象者为0.1–0.4%(p<0.01)。
- 甲状腺危象平均住院日4.8–5.6天,无危象者2.7–3.4天(p<0.001)。
- 经通胀调整的甲状腺危象住院费用从2004年9942美元升至2013年12,660美元(p<0.01)。
临床怎么用
- 临床上对甲状腺毒症住院患者应警惕甲状腺危象,其死亡风险显著更高且住院时间更长。
- 甲状腺危象带来的住院经济负担持续上升,提示需关注其识别与管理效率。
局限性
- 原文摘要未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Current evidence on the incidence and outcomes of patients with thyroid storm in the United States is limited to single-center case series. This study determined the national incidence of thyrotoxicosis with and without thyroid storm and clinical outcomes among hospitalized patients during a 10-year period in the United States. METHODS: Retrospective longitudinal analysis was conducted of clinical characteristics, mortality, hospital length of stay, and costs from 2004 to 2013. Adults (≥18 years of age) with a primary diagnosis of thyrotoxicosis with and without thyroid storm were included. To determine the incidence, outcomes, and cost of thyrotoxicosis with and without thyroid storm, the study used data from the National Inpatient Sample database, the largest public inpatient database, with a representative sample of all non-federal hospitals in the United States. RESULTS: Among 121,384 discharges with thyrotoxicosis during the study period (Mage ± standard error = 48.7 ± 0.11 years; 51.9% Caucasian; 77.3% female), 19,723 (16.2%) were diagnosed with thyroid storm. During the past decade, the incidence of thyroid storm ranged between 0.57 and 0.76 cases/100,000 U.S. persons per year, and 4.8 and 5.6/100,000 hospitalized patients per year. Thyroid storm was associated with significantly higher hospital mortality (1.2-3.6% vs. 0.1-0.4%, p < 0.01) and longer length of stay (4.8-5.6 vs. 2.7-3.4 mean days, p < 0.001) compared to patients with thyrotoxicosis without storm. Inflation-adjusted hospitalization costs progressively increased in patients with thyroid storm from $9942 to $12,660 between 2004 and 2013 (p < 0.01). CONCLUSIONS: One of every six discharges for thyrotoxicosis was diagnosed with thyroid storm. Thyroid storm is associated with a 12-fold higher mortality rate compared to thyrotoxicosis without storm. The incidence and mortality of thyroid storm has not substantially changed in the past decade. However, hospitalization costs have significantly increased.
引用
- Galindo RJ, Hurtado CR, Pasquel FJ, et al. National Trends in Incidence, Mortality, and Clinical Outcomes of Patients Hospitalized for Thyrotoxicosis With and Without Thyroid Storm in the United States, 2004-2013. Thyroid. 2018. PMID: 30382003. doi:10.1089/thy.2018.0275
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。